Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Oct;23(10):489-490.
doi: 10.5005/jp-journals-10071-23271.

Trientine-induced Rhabdomyolysis in an Adolescent with Wilson's Disease

Nagehan Aslan  1 , Sibel Yavuz  2 , Dincer Yildizdas  1 , Ozden Ozgur Horoz  1 , Yasemin Coban  1 , Gokhan Tumgor  2 , Aysun Karabay Bayazit  3
Affiliations
Case Reports

Trientine-induced Rhabdomyolysis in an Adolescent with Wilson's Disease

Nagehan Aslan et al. Indian J Crit Care Med. 2019 Oct.

Abstract

Background: Drugs are very important in the etiology of nontraumatic rhabdomyolysis.

Case descriptions: A 16-year-old male patient with Wilson's disease was admitted for myoclonic contractions. Oral trientine was started for neurological problems and tremor on the hands due to D-penicillamine 1 month ago. Patient was oligoanuric, and his creatine kinase level was 15197 U/L. Rhabdomyolysis was associated with trientine, and trientine treatment was stopped. Hemodiafiltration was performed. The patient began to urinate on the 24th day.

Conclusion: This is the first pediatric patient with rhabdomyolysis induced by trientine. Drugs used should be questioned carefully in patients with rhabdomyolysis.

How to cite this article: Aslan N, Yavuz S, Yildizdas D, Horoz OO, Coban Y, Tumgor G, et al. Trientine-induced Rhabdomyolysis in an Adolescent with Wilson's Disease. Indian J Crit Care Med 2019;23(10):489-490.

Keywords: Continued renal replacement therapy; Rhabdomyolysis; Trientine.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Fig. 1
Fig. 1
CK levels measurements
See this image and copyright information in PMC

References

    1. Vanholder R, Sever MS, Erek E, Lameire N. J Am Soc Nephrol. 2000;11:1553–1561. - PubMed
    1. Ward MM. Factors predictive of acute renal failure in rabdomyolisis. Arch İntern Med. 1998;148:1553–1557. - PubMed
    1. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 2005;84:377–385. - PubMed
    1. Epstein O, Sherlock S. Triethylene tetramine dihydrochloride toxicity in primary biliary cirrhosis. Gastroenterology. 1980;78(6):1442–1445. - PubMed
    1. Lu J. Triethylenetetramine pharmacology and its clinical applications. Mol Cancer Ther. 2010;9:2458–2467. - PubMed

Publication types

LinkOut - more resources